10.1016/j.brainresbull.2014.04.011 Brain Res
an advisory board member for Pfizer, AstraZeneca, Zealand Pharma and Carmot/Roche
Di Stefano a, b , Elizabeth Velsquez a , Paul Anthony Camacho a,c , Patricio Lpez-Jaramillo a, b a Direccin de Investigaciones, Desarrollo e Innovacin Tecnolgica, Fundacin Oftalmolgica de Santander (FOSCAL), Floridablanca, Colombia b Instituto MASIRA, Facultad de Medicina, Universidad de Santander (UDES), Bucaramanga, Colombia c Facultad de Ciencias de la Salud, Universidad Autnoma de Bucaramanga (UNAB), Bucaramanga, Colombia Recibido el 1 de julio de 2015
This inositol paradox causes a marked reduction in the MI/DCI ratio in ovarian follicular fluid compared to healthy controls (0.2:1 in PCOS patients vs
Daxxify, a neuromuscular blocking agent and acetylcholine release inhibitor thats positioned as a rival to AbbVies Botox, was approved in September 2022 for the temporary improvement of moderate to severe frown lines in adults